Loading clinical trials...
Loading clinical trials...
The study proposes to correlate the plasma dosage of VEN with the inhibition of its Bcl-2 target during the first treatment cycle. VEN will be measured sequentially during the first treatment cycle an...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire de Nice
NCT06197672 · Acute Myeloid Leukemia
NCT06285890 · Acute Myeloid Leukemia
NCT07425782 · Acute Myeloid Leukemia, Consolidation Therapy, and more
NCT05429632 · Adult Acute Myeloid Leukemia
NCT06138587 · Acute Myeloid Leukemia, Leukemia, and more
Hopital la Conception
Marseille
CHU de Nice
Nice
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions